Curtis Gale Oltmans Avenue Therapeutics, Inc. (ATXI) insider trading activity
Curtis Gale Oltmans is Director of AVENUE THERAPEUTICS, INC.. Currently has a direct ownership of 49,020 shares of ATXI, which is worth approximately $96,569. The most recent transaction as insider was on Dec 17, 2021, when has been sold 49,020 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
49K
0%
3M change
0%
12M change
Total Value Held
$96,569
Curtis Gale Oltmans Transaction History
Also insider at
CGO
Curtis Gale Oltmans
Director
Cambridge, MA